Inventor
HALLAHAN DENNIS E
US33 patents
⚠️ This page may combine multiple inventors who share the name “HALLAHAN DENNIS E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV VANDERBILT
9 patentsUS6159443ADec 12, 2000
X-ray guided drug delivery
UNIV VANDERBILT95 citations98
US7402392B2Jul 22, 2008
In vivo panning for ligands to radiation-induced molecules
UNIV VANDERBILT24 citations92
US7049140B1May 23, 2006
X-ray guided drug delivery
UNIV VANDERBILT39 citations92
US7906102B2Mar 15, 2011
Ligands to radiation-induced molecules
UNIV VANDERBILT15 citations91
US7306925B2Dec 11, 2007
Phage antibodies to radiation-inducible neoantigens
UNIV VANDERBILT23 citations91
US7968675B2Jun 28, 2011
In vivo panning for ligands to radiation-induced molecules
UNIV VANDERBILT12 citations83
US8927288B2Jan 6, 2015
Phage antibodies to radiation-inducible neoantigens
UNIV VANDERBILT4 citations82
US8012945B2Sep 6, 2011
Phage antibodies to radiation-inducible neoantigens
UNIV VANDERBILT10 citations82
US7875454B2Jan 25, 2011
X-ray guided drug delivery
UNIV VANDERBILT4 citations63
HALLAHAN DENNIS E
9 patentsUS8771754B2Jul 8, 2014
Use of GSK3 inhibitors in combination with radiation therapies
HALLAHAN DENNIS E23 citations92
US8388932B2Mar 5, 2013
Ligands to radiation-induced molecules
HALLAHAN DENNIS E11 citations91
US8101157B2Jan 24, 2012
Ligands to radiation-induced molecules
HALLAHAN DENNIS E13 citations84
US9340581B2May 17, 2016
Ligands to radiation-induced molecules
HALLAHAN DENNIS E6 citations82
US8765097B2Jul 1, 2014
Ligands to radiation-induced molecules
HALLAHAN DENNIS E8 citations82
US8617521B2Dec 31, 2013
Phage antibodies to radiation-inducible neoantigens
HALLAHAN DENNIS E7 citations82
US10086073B2Oct 2, 2018
Ligands to radiation-induced molecules
HALLAHAN DENNIS E2 citations71
US8740762B2Jun 3, 2014
Specific inhibition of cPLA2 enhances the efficacy of radiotherapy
HALLAHAN DENNIS E0 citations42
US8129356B2Mar 6, 2012
Bmx mediated signal transduction in irradiated vascular endothelium
HALLAHAN DENNIS E0 citations42
ARCH DEV CORP
7 patentsUS5962424AOct 5, 1999
Methods and compositions for targeting selectins
ARCH DEV CORP64 citations96
US5770581AJun 23, 1998
Gene transcription and ionizing radiation: methods and compositions
ARCH DEV CORP74 citations96
US6605712B1Aug 12, 2003
Gene transcription and ionizing radiation: methods and compositions
ARCH DEV CORP25 citations92
US6156736ADec 5, 2000
Gene transcription and ionizing radiation: methods and compositions
ARCH DEV CORP21 citations92
US5817636AOct 6, 1998
Control of gene expression by ionizing radiation
ARCH DEV CORP21 citations92
US5641755AJun 24, 1997
Regulation of x-ray mediated gene expression
ARCH DEV CORP31 citations92
US6486170B1Nov 26, 2002
Phospholipase A2 inhibitors as mediators of gene expression
ARCH DEV CORP2 citations63
UNIV WASHINGTON
4 patentsUS10259884B2Apr 16, 2019
Antibodies to GRP78
UNIV WASHINGTON6 citations80
US10449261B2Oct 22, 2019
Compositions targeting radiation-induced molecules and methods of use thereof
UNIV WASHINGTON0 citations52
US10066008B2Sep 4, 2018
Monoclonal antibodies to human 14-3-3 epsilon and human 14-3-3 epsilon sv
UNIV WASHINGTON0 citations48
US9738725B2Aug 22, 2017
Antibodies to TIP-1
UNIV WASHINGTON1 citations48